Evidence map

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Efficacy and Safety of Adding Empagliflozin to Liraglutide on Renal Function in Patients with Advanced-Stage Type 2 Diabetic Kidney Disease: A Randomized Controlled Trial.

Kae Sunagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39430135